Wearable Technology for Cancer

(WISE Trial)

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Alabama at Birmingham
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how wearable technology can enhance cancer care by remotely tracking symptoms. Participants will use a wearable device to record health data such as sleep, activity, and heart rate, aiming to provide better and more timely care. The trial also seeks to identify challenges and solutions for effective device use. Ideal candidates for this trial are cancer patients enrolled in the ePRO RSM program who own a compatible smartphone. As an unphased trial, this study offers patients the opportunity to contribute to innovative research that could improve future cancer care.

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on using wearable technology for monitoring symptoms, so it's likely you can continue your medications, but you should confirm with the trial organizers.

What prior data suggests that this wearable is safe for patients receiving cancer treatment?

Studies have shown that wearable devices, such as smartwatches and fitness trackers, are generally safe for people, including those with cancer. These devices often monitor health information like heart rate and activity levels. They meet safety standards set by the Federal Communications Commission (FCC) to ensure safety for everyday use.

Research indicates that cancer patients can use these devices without significant side effects. No major reports have specifically linked wearables to problems during cancer treatment. This suggests that wearables are a safe option for tracking health data, potentially improving care and treatment outcomes.12345

Why are researchers excited about this trial?

Researchers are excited about the wearable technology for cancer because it offers a non-invasive way to continuously monitor patients' physiological health metrics, such as sleep, activity, and heart rate variability. Unlike traditional treatments that might rely on periodic check-ups and subjective reporting of symptoms, this wearable provides real-time data, potentially leading to more personalized and timely interventions. By tracking these metrics, clinicians can gain insights into how lifestyle factors impact cancer progression and treatment efficacy, paving the way for more responsive and tailored care.

What evidence suggests that this wearable is effective for cancer care?

This trial will explore the use of wearable devices for cancer patients. Studies have shown that these devices can track important health indicators, such as heart rate and daily steps, which might help predict patient outcomes. Research suggests that wearables can enhance physical health for patients undergoing treatments like chemotherapy. By offering continuous health monitoring, they could lead to better cancer care management. Wearables are seen as a promising tool to enhance the patient experience during cancer treatment by providing real-time data that helps doctors deliver timely and efficient care. Overall, these devices are being explored for their potential to improve monitoring and care in cancer treatment settings.13678

Who Is on the Research Team?

GR

Gabrielle Rocque, MD

Principal Investigator

University of Alabama at Birmingham

Are You a Good Fit for This Trial?

This trial is for adults (18+) diagnosed with cancer who use a smartphone compatible with the wearable device and are enrolled in a remote symptom monitoring program at O'Neal CCC. People who can't speak or read English, or have medical issues that prevent participation, cannot join.

Inclusion Criteria

I am 18 years old or older.
I have been diagnosed with cancer.
Uses a smart phone compatible with the wearable
See 1 more

Exclusion Criteria

Lack of English fluency and literacy
Medical condition that makes the person unable to participate, at PI discretion.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use a wearable device to track physiological health metrics while receiving cancer treatment

6 months
Regular remote monitoring

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Wearable

Trial Overview

The study is testing if using a wearable device can help monitor symptoms remotely for people undergoing cancer treatment. It looks at how well the wearable works alongside electronic symptom reporting and explores any challenges in using this technology.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Patient Group - WearableExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+

Breast Cancer Research Foundation of Alabama

Collaborator

Citations

The Use of Wearable Devices in Oncology Patients - PMC - NIH

This article summarizes the current literature on wearable technologies in oncology patients for the purpose of prognostication, treatment monitoring, and ...

“Tracking Health: How Wearable Technology Is ...

Several studies have reported that WD can facilitate the routine monitoring of vital signs of cancer patients, including heart rate, respiratory ...

Wearable Devices Help Monitor Patient Health After Cancer ...

Researchers evaluate whether devices that track health metrics like daily steps and heart rate can help predict clinical outcomes.

The association between wearable device metrics and ...

The emerging study of wearable devices (WDs) in patients with cancer provides opportunities to harness real-time patient data for predicting clinical outcomes.

Wearables research for continuous monitoring of patient ...

This scoping review assesses the current state of the literature on wearable devices for remote health monitoring in non-hospital settings.

Facts About Wearable Technology

To be sold in the United States, all such devices must meet Federal Communications Commission (FCC) limits for human exposure to RF radiation.

Exploring the Potential Use of Wearable Devices as a ... - PMC

Wearable devices can be used to objectively measure performance status in patients with advanced cancer [27]. Continuous health monitoring via wearables was ...

Mobile/wearable digital devices for care of active cancer patients

Our results reinforce current evidence that physicians are prone to use mobile/wearable digital devices for AF detection and monitoring in both ...